Clinical Trials on Nocturnal Polyurea in Patients With BPH in Singapore
Total 1 results
-
Paul OngUnknownRefractory Thrombus in Patients With Acute Coronary SyndromeSingapore
Sponsors and Collaborators
- IN-JET APS
- Prof. Jacques SCHRENZEL
- Custom Pharmaceuticals Limited
- JMI Laboratories
- Familien Hede Nielsens Fond
- Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
- UZ Leuven, campus Pellenberg (Belgium)
- Nestlé Health Science Belgium
- The Fred Hollows Foundation, Australia
- Markham Stouffville Hospital
- Dr. Praveen B.H
- Hazelden Betty Ford Foundation
- Pedro Gamito
- Universitatea de Medicina si Farmacie Iuliu Hatieganu
- Hospital Samaritano Paulista
- Janssen (China) Research & Development Center
- Advanced Life Solutions
- Physip S.A
- Stannah Stairlifts
- Fogarty International Center of the National Institute of Health
- View Full List
Medical Conditions
- Skull Base Neoplasms
- Gullian Barre Syndrome
- Pulmonary Adenocarcinoma
- Epidemic Hemorrhagic Fever
- Psoriasis, Arthritic
- Painless Hysteroscopy
- Predictors of Atrial Fibrillation Recurrences
- Closure; Foramen Ovale
- Tay-Sachs Disease Ganglioside
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Endocarditis Infective
- Fracture Dislocation of Cervical Spine
- Fetus or Neonate Affected by External Version Before Labor
- Childhood Langerhans Cell Histiocytosis
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Ewing's Family Tumors
- Multisystem Proteinopathy
- Spine Surgeries
- Chlamydophila Infections
- View Full List
Drug Interventions
- Semapimod
- Glimepiride
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Estradiol+Drospirenone
- Esomeprazole 40mg before
- Qingkailing injection 40 ml
- Cereport
- Azelastine hydrochloride (BAYR9258)
- Chemotherapeutic Agent
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Neihulizumab
- Adapalene Gel 0.3%
- Redifferentiation with retinoid acid
- High dose pantoprazole infusion
- Palliative care group first-line scheme
- Adriamycin
- EFV +TVA
- Vehicle
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- View Full List
CROs by country
- Contract Research Organizations in Belgium
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Denmark
- Contract Research Organizations in Egypt
- Contract Research Organizations in France
- Contract Research Organizations in Gambia
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Panama
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Suriname
- Contract Research Organizations in Venezuela
- CRO list by country